Kindlin-2 functional restoration through methylmalonic acid clearance by coenzyme A counteracts osteoporosis

Xuling Li1, Guixing Ma1, Fen Wang1

  • 1Department of Biochemistry, SUSTech Homeostatic Medicine Institute, School of Medicine, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Key University Laboratory of Metabolism and Health of Guangdong, Southern University of Science and Technology, Shenzhen 518055, China.

Insights

Old blood components accelerate skeletal aging by increasing methylmalonic acid (MMA). This molecule targets Kindlin-2, but coenzyme A (CoA) can reverse these effects, offering a potential therapy for osteoporosis.

Area of Science:

  • Biogerontology
  • Skeletal Biology
  • Molecular Mechanisms of Aging

Background:

  • Old blood is known to induce senescence, but the specific molecular drivers of age-related skeletal decline are not fully understood.
  • Non-protein components of aged serum contribute to skeletal aging phenotypes in younger organisms.

Purpose of the Study:

  • To identify the key molecular components in aged serum responsible for inducing skeletal aging.
  • To elucidate the mechanism by which these components affect bone health.
  • To explore potential therapeutic interventions for age-related bone loss.

Main Methods:

  • Administration of aged human serum (non-protein components) to young mice.
  • Identification of methylmalonic acid (MMA) as a key aging factor using biochemical assays.
  • Photoaffinity labeling to identify the intracellular receptor for MMA.
  • Analysis of MMA binding to Kindlin-2 and its downstream effects (ubiquitination, degradation).
  • Treatment with coenzyme A (CoA) to assess its therapeutic potential in mouse models of aging and estrogen deficiency.

Main Results:

  • Non-protein components of aged human serum (ONP) induced skeletal aging in young mice.
  • Methylmalonic acid (MMA) was identified as a key driver of these aging phenotypes.
  • Kindlin-2 was confirmed as a direct intracellular MMA receptor, with MMA binding promoting its degradation.
  • Coenzyme A (CoA), an endogenous MMA scavenger, reversed MMA- and ONP-induced skeletal aging.
  • CoA treatment also protected against age-related bone loss and bone mass reduction in aged and estrogen-deficient mice.

Conclusions:

  • Methylmalonic acid (MMA) is a critical factor in age-related skeletal decline, acting via the intracellular receptor Kindlin-2.
  • Targeting MMA or enhancing its clearance, for example, with coenzyme A (CoA), represents a promising therapeutic strategy for osteoporosis and other age-related bone diseases.

Related Concept Videos

Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...